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Abstract 
 
Gynura procumbens is widely used as traditional remedy in South-East Asia. Gynura 
procumbens exhibites anti inflammatory, antioxidant, and reduced blood pressure activity. The 
aim of this study was to determine chromatographic profile of ethyl acetate fraction of Gynura 
procumbens (FEG) and to investigate its cytotoxic properties and selectivity to colon cancerand 
breast cancer cancer cells. The chromatographic profile of FEG was determined using HPTLC 
densitometric and HPLC. MTT (3-(4,5-dimethyl-thiazol-2-yl)-2,5-diphenyltetrazolium bromide) 
assay was performed to determine the growth inhibitory effect of FEG on the growth of WiDr, 
MCF-7, and T47D cells. NIH3T3, a normal cells was used to determine the selectivity of FEG, 
which contained small amount of quercetin as identified from chromatographic profile both 
HPTLC and HPLC. FEG inhibited cell growth of WiDr, of MCF-7 and of T47D cells in time 
dependent manner. Quercetin affected cell growth inhibition approximately two fold higher at 
WiDr and MCF-7, whereas FEG had lower effect on T47D cell. Quercetin did not seem as the 
main active compound of FEG. At this study, FEG caused less inhibition on the growth of 
NIH3T3 cells than that of on all cell lines. Selectivity index (SI) of FEG on WiDr, MCF-7 and 
T47D were 4.97, 2.77 and 7.79 respectively. According to the datas obtained, FEG possesses 
moderate to high cytotoxicity properties on WiDr, MCF-7 and T47D cells. FEG demonstrates 
selective effect against cancer cells and reveals prospective properties as cancer 
chemoprevention agent.  
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INTRODUCTION 
 
Breast cancer and colon cancer are the two 
of the most five deadly cancer diseases together 
with lung cancer, stomach cancer and 
hepatocarcinoma. Approximately 1,2 million cases 
of colorectal cancer are expected to occur in 2007. 
While 1,3 million new cases of invasive breast 
cancer are expected in 2007 (Garcia et al., 2007). 
Breast cancer caused 519.000 death per year, while 
colon cancer causes 639.000 patient death per year 
(WHO, 2006). In Indonesia, breast cancer 
prevalence is the second range after cervix cancer 
and become the major caused on women mortality.  
Combination therapy using surgery, 
chemotherapy and radotherapy resulted 
dissatisfied achievement. Many cancer 
chemotherapeutic drugs present relatively poor 
selectivity for neoplastic cells. The failure of 
cancer chemotherapy partly is resulted from the 
low selectivity of anticancer drugs and the unclear 
of molecular target on cancer. Drugs with low 
selectivity affect several side effect on patient. 
Research efforts have been carried on to overcome 
these problems by developing more effective and 
selective anticancer drugs through consideration of 
the molecular target and mechanisms. Plant 
bioactive compounds are normally cheaper and 
produce lower side effects respected to 
chemotherapy.  
Thus, the searching for active compounds 
extracted from plant is an important path of 
research in the discovery of novel anticancer 
candidates. Gynura procumbens (G. procumbens) 
is a medicinal plant with several biological activity 
related with anticancer. G. procumbens extract and 
its fractions exhibit high antioxidant properties 
shown by xantine oxidase inhibition and radical 
scavenging activity. 
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 The uncontrolled production of radical 
oxygen species (ROS) and unbalance antioxidant 
protective system have an important part on cancer 
initiation and development (Rosidah et al., 2008). 
These natural antioxidants may become a 
beneficial agent to be developed as 
chemoprevention substance for cancer disease. G. 
procumbens inhibited carcinogenesis process of 
lung cancer (Sugiyanto et al., 2003) and breast 
cancer (Meiyanto et al., 2007a; Meiyanto et al., 
2007b) and has antimutagenic properties on 
benzo(a)pyrene-induced mice lung cancer 
(Meiyanto, 1996). The phenolic compounds of G. 
procumbens suppressed cells proliferation and 
induced apoptosis at HeLa (Meiyanto dan 
Septisetyani, 2005), and T74D cells (Maryati, 
2006), and also has antiangiogenic properties 
(Jenie et al., 2007). Phenolic compounds of G. 
procumbens decreased Cox-2 expression (in vivo) 
and elevated p53 and Bax expression (in vitro) 
(Maryati et al., 2006).  
 To our knowledge, no specific study had 
been reported addressing the selective cytotoxic 
effects of FEG on colon cancer WiDr and breast 
cancer MCF-7 and T47D and normal NIH3T3 cell 
lines. Thus, in this present study, we have 
evaluated the in vitro cytoxicity of FEG on those 
cells. Results from both cancerous and normal cell 
were then compared to determine the selective 
activity. 
 
MATERIALS AND METHODS 
 
Chemicals and Reagents 
Material were used in this study: DMEM 
(Nacalay, Japan), Fetal Bovine Serum (FBS) 
(PAA), Dimethyl sulfoxide (DMSO) (Sigma, 
Aldrich, Germany), penicillin and streptomycin 
(Gibco), tripsin (Sigma), 3-(4,5-dimethyltiazol-2-
il)-2,5-diphenyltetrazolium bromide (MTT),  
sodium dodecyl sulphate (SDS). Tris–HCl, 
ethanol, n-hexane, and ethyl acetate and fraction of 
ethyl acetate G. procumbens (FEG). The fractions 
was dissolved in DMSO with 0,1% as maximum 
concentration. All of the chemicals were on the 
higher degree of quality. 
 
Human cell lines 
Human colon cancer cell WiDr and breast 
cancer cell MCF-7 and T47D was provided from 
Cancer Chemoprevention Research Centre 
(CCRC) collection. NIH3T3 cell was kindly 
provided from Prof. Masashi Kawaichi, 
Laboratorium of Gene Function in Animal, Nara 
Institute of Science and Technology. WiDr cells 
were cultured in Rosewell Park Memorial Institute 
(RPMI) containing 10% heat-inactivated fetal 
bovine serum (FBS) 1 % Penicillin-streptomycin 
(v/v), and L-glutamine (1 mM) at 37
o
C and 5% 
CO2. MCF-7 and T47D cells were routinely 
grown in Dulbecco’s modified eagle’s medium 
(DMEM) and added the same supplement as that 
to RPMI medium. NIH3T3 cells were routinely 
grown in DMEM supplemented with 10% heat-
inactivated fetal calf serum (FCS) (PAA 
Labortories), 1 % Penicillin-streptomycin (v/v), 
and L-glutamine (1 mM) at 37
o
C and 5% CO2. 
 
Plant material 
The leaves of G. Procumbens were obtained 
from the collection of Balai Penelitian dan 
Pengembangan Tanaman Obat dan Obat 
Tradisional (BP2TO2T) Indonesia, and was 
determined at Laboratorium of Pharmacognocy, 
Faculty of Pharmacy Gadjah Mada University, 
Indonesia. Dry powder of Gynura procumbent was 
re-macerated with 96 % ethanol for three time with 
three days maceration for each process. All filtrate 
then evaporated using rotary evaporator until a 
thick liquid extract was obtained. The ethanolic 
extract was dissolved in hot aquadest then 
fractionated using n-hexane. The water fraction 
then continued to fractionate with ethyl acetate. 
The ethyl acetate fraction was evaporated using 
rotary evaporator. The ethyl acetate extract was 
concentrated by evaporation under reduced 
pressure and the temperature was kept not more 
than 40
o
C.  The extract was stored at 4
o
C prior to 
use. 
 
Determination of chromatographic profile 
of FEG  
Chromatography profile of FEG was 
determined using high performance thin layer 
chromatography (HPTLC) dan high performance 
liquid chromatography (HPLC). Mobile phase that 
used for HPTLC was 
toluene:chloroform:aceton:acetic acid (4:4:4:1) 
and  using silica gel 60 F254  (Merck) as stationary 
phase. Ultraviolet (UV) detection at 254 nm in 
wave length was used for spot visualization.  The 
all spots were scanned using TLC Scanner 
(CAMAG), deuterium and wolfram (D2 & W) 
lamp, at 380 nm. Coloumn silica Symmetry C18 
(lenght x internal diameter: 150 mm x 4.6 mm, 
particle size 15 mm) was used as stationery phase 
for HPLC. The mobile phase was acetonitrile: 
formic acid (25:75). The eluent was detected by 
ultraviolet-visible (UV-VIS) detector at 360 
visualization of the spot. Quercetin (QUER) 
(Sigma-Aldrich, 98% HPLC, CAS No. 117-39-
5)) and kaempferol (KAEMP) (Sigma-Aldrich, 
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90% HPLC, CAS No. 520-18-3) were used as 
marker.  
 
Cytotoxicity assessments 
Cells (10
4 
cells/well) were cultured at 96-
well plate. After 24 hours growth, cells culture 
medium was replaced with 5-FU, CISP, and/or 
FEG-contained medium. After incubated for 24 
hours, the medium was replaced with MTT-
containing medium (0,5 mg/mL) and incubated for 
4 hours at 37
o
C, 5 % CO2. The reaction was 
stopped with 10% SDS in 0,1 N HCl solution and 
was incubated for overnight in light protected 
chamber, to dissolve formasan salt. The 
absorbance of each well was measured with 
ELISA reader at 595 nm. The ratio between treated 
and control cells absorbance refer to percentage 
(%) of viable cells. 
 
Selectivity index (SI) 
In the present study, the degree of 
selectivity of FEG refered to the previous report  
(Badisa et al., 2006), was calculated using 
formula: SI=LC50 in normal cells /LC50 in cancer 
cell lines, where LC50 is the concentration 
required to kill 50% of the cell population.  
 
RESULTS AND DISCUSSION 
 
Chromatography profile of ethyl acetate 
fraction of Gynura procumbens 
Ethyl acetate fraction of Gynura 
procumbens was fractionated twice separately, 
produced two different batch of ethyl acetate 
fraction (FEG). This FEG was obtained from 
liquid-liquid fractionation of ethanolic extract 
using n-heksane-hot water and continued with 
ethyl acetate-water. From the two fractionations 
were obtained percentage of FEG 1,6 % and 1,7 
%, respectively. FEG was analized its 
chromatographic profile using High Performance 
Thin Layer Chromatography (HPTLC) and High 
Performance Liquid Chromatography (HPLC) as 
shown on Fig. 1 and 2 respectively. Quercetin 
(QUER) and  kaempferol (KAEMP) were used as 
marker compound. Both FEG from different batch 
had similar chromatographic profile as result of 
HPTLC and HPLC. Most of chromatogram refered 
to flavonoid compound. From the scanning of 
maksimum wave lenght we concluded FEG may 
contained quercetin, but not kaempferol. However 
the amount of quercetin was not dominated the 
active compound of FEG.  
 
Inhibitory effect of FEG on WiDr, MCF-7 
and T47D cells growth 
To determine the potency of FEG as 
anticancer agent, first the cytotoxicity properties 
were examined in WiDr colon cancer cell, MCF-7 
and T47D breast cancer cells. Cell viability was 
examined using MTT assay method after 24 hours 
incubation. FEG caused cell growth inhibition on 
WiDr, MCF-7 and T47D cells in dose dependent 
manner with IC50 value 119 μg/mL, 214 μg/mL 
and 76 μg/mL, respectively (Table I). FEG had 
moderate to high potency as cytotoxic agent. The 
highest potency was shown on T47D cell. 
Quercetin also caused cell growth inhibition on 
three cells in dose dependent manner with IC50 
value 56 μg/mL, 169 μg/mL, 127 μg/mL, 
respectively. These results demonstrated that 
quercetin was not the main active compound of 
FEG.  
 
FEG shows lower cell growth inhibition in 
normal cells than that of cancer cells 
Cytotoxicity results showed moderate to 
high potency of FEG to be developed as anticancer 
agent. In order to determine the selectivity of FEG, 
we performed cytotoxic properties of FEG on 
normal cells, NIH3T3 (Fig.3). FEG gave no 
significant effect up to 400 μg/mL on NIH3T3 cell 
growth after 24 hours incubation. While after 72 
hours, FEG caused cell growth inhibition at 
minimal concentration 600 μg/mL. IC50 value of 
FEG was measured after 24 and 72 hours of FEG 
treatment, resulted 592 μg/mL and 538 μg/mL, 
respectively.  FEG shows lower cell growth 
inhibition in NIH3T3 than that in WiDr, MCF-7 
and T47D cells. FEG shows lower inhibition on 
the growth of normal cells than that of cancer cell. 
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Figure I.  Chromatogram profile of FEG was compared with Quercetin (QUER) and Kaempferol (KAEMP) 
as marker using HPTLC. FEG, QUER and KAEMP wre analized using HPTLC with silica gel 60 
F254 as stationary phase and toluene:kloroform:aseton:asam asetat (4:4:4:1) as mobile phase 
(Lalla et al., 2003). Silica plate was visualized under UV light 254 nm then scanned using 
densitometer, 380 nm.  
 
 
Figure 2.  Chromatogram profile of FEG-contained compounds using HPLC. Chromatogram profile of 
FEG1 (A), FEG2 (B), and QUER (C). FEG and QUER were diluted in ethyl acetate with the 
indicated concentrations as described at method. FEG and quercetin solution was analyzed using 
HPC with Asetonitril: asam formiat (25:75) as mobile phase and silica coloumn symmetry C18, 
detector UV-VIS. 
Nurulita, et al., 2011 
Indones. J. Cancer Chemoprevent., 2(3), 274-280  
 
 
278 
 
Figure 3. The effect of FEG on NIH3T3 cells growth. FEG treatment up to 400 μg/mL caused no significant 
cell growth inhibition. Cells (104 cells/well) were seeded at 96-well plate. After 24 hours growed, 
cells were treated with FEG (0-1000 μg/mL) for 24 and 72 hours. Cells viability were determined 
using MTT assay. T Test analysis, with 95% confidency was used to conclude the significance of 
cells growth inhibition. *FEG inhibit cell growt significantly (p>0,05).  
 
Table I. IC50  Value of FEG and  QUER on WiDr, MCF-7 and T47D cells and The selectivity index (SI) which 
represents IC50   of FEG for normal cell line/IC50 for cancerous cell line after 24 hours incubation 
treatment. 
Cells Sample IC50 Value* Selectivity Index 
(SI) 
WiDr FEG 119   μg/mL 4.97 
 QUER 56    μg/mL  
MCF-7 FEG 214   μg/mL 2.77 
 QUER 169   μg/mL  
T47D FEG 76     μg/mL 7.79 
 QUER 127   μg/mL  
         *represented from al least 2 (two) independent experiments. 
 
 
Many researchers are now interested in 
examining the use of herbal medicines as a health 
care method. Herbal medicines continue to be 
accepted forms of treatment in the Orient, and the 
plant derived drugs based on traditional practices 
represent a huge proportion of the pharmaceutical 
production in modern Western countries (Newall 
et al., 1996 Schulz et al., 1998). Development of 
biologically targeted agents that exploit differences 
between cancerous and normal cells and permit 
greater specificity for cancer cells with less 
damage to normal cells is still the ultimate goal in 
the field of antineoplastic drug discovery (Adam, 
2001). Until now, no ideal cytotoxicity assay has 
been developed; hence, it is always advisable to 
support results with more assays where possible. 
Besides, it is important that of compare the 
cytotoxicity of a novel compound against several 
cell lines and even with other commercial 
cytotoxic agents. In this study, we showed the 
profile of bioactive compounds of ethyl acetate 
fraction of G. procumbens (FEG). We also 
confirmed the cytotoxicity properties of FEG and 
its selectivity directed human colon cancer and 
breast cancer cells.  
HPTLC analysis of FEG shown three main 
spots, similar with previous results from study of 
Sugiyanto et al., (2003). Previous study showed 3 
(three) main spots that had been identified as 
flavon/flavonol. The first flavonoid was identified 
as flavonol derivate with 5 –OH and 3,7 –OCH3. 
He second flavonoid was flavonol derivate with 
5,7 –OH and 3-Oglucosil. The third flavonoid was 
similar with the second flavonoid. Flavonol 
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derivative that has 7 -alkoksi, 3’ and 4’ di-OH, and 
3,5 di-OH (Sugiyanto et al., 2003). The third 
flavonoid was quercetin derivative with alkoksi 
substitution on 7 –OH. Previous results also found 
quercetin, kaempferol and its derivate in G. 
procumbens (Akowuah et al., 2002). Methanolic 
extract may contain kaempferol-3-O-rutinosida 
dan astragalin (Rosidah et al., 2009), and its 
ethanolic extract has been identified as 
kaempferol-3-O-rutinosida, quercetin-3-O-
rutinosida, dan isobioquercetin compounds (Kim 
et al., 2011). HPLC results of FEG showed 
chromatogram peak with retention time (tR) value 
of 41.7 similar to the tR value of quercetin 41.6. 
Therefore FEG may contain quercetin. However 
there are others compound also contained in the 
chromatogram peak.  
FEG shows moderate to high cytotoxicity 
properties on colon cancer and breast cancer as 
indicated on the IC50 value at WiDr, MCF-7 and 
T47D cells. While quercetin presented higher 
potency (almost 3 fold) on cytotoxicity compared 
to FEG on WiDr and MCF-7 cells.  Conversely 
quercetin demonstrated lower potency on cytotoxic 
properties on T47D cells. This phenomenon may 
cause by different cells characteristic or different 
target of action. The results of cytotoxicity assay 
showed that quercetin does not seem as the main 
active compound of FEG. There are other 
compounds contained in FEG that have pivotal 
portion on its cytotoxicity properties.   
Since FEG had high potency of 
cytotoxicity, its impotant to reveal the selectivity 
of this fraction. FEG produced no significance 
effect on cell growth inhibition up to 400 μg/mL 
concentration  at NIH3T3 cells. Selectivity of FEG 
on WiDr and T47D cells higher than that on T47D. 
FEG exhibited very high selectivity on WiDr and 
MCF-7 cells as shown by selectivity index (SI), 
that is > 3. Even as on MCF-7, FEG demonstated 
moderate selectivity properties.  
 
CONCLUSION 
 
The present in vitro studies FEG possesses 
moderate to high cytotoxicity properties on WiDr, 
MCF-7 and T47D cells. FEG shows selective 
effect against cancer cells. Further FEG reveals 
prospective properties to be developed as cancer 
chemoprevention agent.  
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